Community-based exercise for health promotion and secondary cancer prevention in Canada: protocol for a hybrid effectiveness-implementation study.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
13 09 2019
Historique:
entrez: 15 9 2019
pubmed: 15 9 2019
medline: 21 10 2020
Statut: epublish

Résumé

Cancer care has expanded from a disease-focused, survival-oriented model to an approach that now considers how survivors can live well in the aftermath of intensive therapy, where they may deal with significant changes to their bodies, mental health or emotional well-being. Research evidence supports the benefit of exercise during and following cancer treatments for cancer-related symptoms, physical functioning and fitness, and health-related quality of life. To move this efficacy evidence into practice, we designed and launched a 5-year study to evaluate the relative benefit from implementing a clinic-to-community-based cancer and exercise model of care. A hybrid effectiveness and implementation trial design is being used to evaluate the effectiveness of delivery of community-based exercise and to collect data on implementation of the programme. The study opened in January 2017, with estimated completion by January 2022. The programme will be delivered in seven cities across the province of Alberta, Canada, with sites including three academic institutions, six YMCA locations, Wellspring Edmonton and Calgary, and six municipal fitness centres. Participants are adult cancer survivors (n=2500) from all tumour groups and stages and at any time point along their cancer treatment trajectory, up to 3 years post treatment completion. Survivors take part in a minimum of 60 min of mild-to-moderate intensity full body exercise twice weekly for a 12-week period. The primary effectiveness outcome is the proportion of participants meeting or exceeding 150 min of moderate intensity exercise per week at 1-year follow-up. The Reach, Effectiveness, Adoption, Implementation and Maintenance (RE-AIM) framework will be utilised to capture individual-level and organizational-level impact of the exercise programme at 12 and 24 weeks and 1-year follow-up. The cohort of survivors participating in the study will allow for long-term (>5-year) evaluation of rates of cancer recurrence and secondary cancers beyond the funding period. The study was approved by the Health Research Ethics Board of Alberta. The study is funded by Alberta Innovates and the Alberta Cancer Foundation. The study will help to answer critical questions on the effectiveness of cancer-specific community-based exercise programming in both the short-term and the long-term. Collectively, the findings will help to inform the acceptability, adoption, feasibility, reach and sustainability of community-based exercise. NCT02984163; Pre-results.

Identifiants

pubmed: 31519676
pii: bmjopen-2019-029975
doi: 10.1136/bmjopen-2019-029975
pmc: PMC6747880
doi:

Banques de données

ClinicalTrials.gov
['NCT02984163']

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e029975

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Clin Oncol. 2006 Aug 1;24(22):3535-41
pubmed: 16822843
Percept Mot Skills. 2015 Apr;120(2):604-22
pubmed: 25799030
Curr Oncol. 2017 Aug;24(4):e290-e315
pubmed: 28874900
Int J Sports Phys Ther. 2012 Jun;7(3):306-13
pubmed: 22666645
J Clin Oncol. 2011 Feb 20;29(6):726-32
pubmed: 21205749
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
Psychooncology. 2013 Jan;22(1):186-94
pubmed: 23296635
Clin Orthop Relat Res. 2014 Aug;472(8):2536-41
pubmed: 24817380
J Orthop Sports Phys Ther. 1992;16(5):215-9
pubmed: 18796752
J Clin Oncol. 2015 Jun 10;33(17):1918-27
pubmed: 25918291
Med Sci Sports Exerc. 2011 Aug;43(8):1575-81
pubmed: 21681120
J Oncol Pract. 2012 Nov;8(6):320-4, 2 p following 324
pubmed: 23598839
J Pain Symptom Manage. 1997 Feb;13(2):63-74
pubmed: 9095563
Med Sci Sports Exerc. 2010 Jul;42(7):1409-26
pubmed: 20559064
CA Cancer J Clin. 2012 Jul-Aug;62(4):243-74
pubmed: 22539238
Res Q Exerc Sport. 2003 Sep;74(3):331-6
pubmed: 14510299
Psychooncology. 2014 Feb;23(2):204-15
pubmed: 24009181
J Clin Oncol. 2017 Nov 10;35(32):3635-3637
pubmed: 28915086
Gerontol Geriatr Med. 2019 Jan 22;5:2333721418823604
pubmed: 30733977
Annu Rev Public Health. 2007;28:413-33
pubmed: 17150029
Gait Posture. 2011 Apr;33(4):737-9
pubmed: 21444208
Int J Sports Med. 2013 Jul;34(7):631-6
pubmed: 23444095
Physiother Can. 2016;68(4):383-390
pubmed: 27904238
Curr Oncol. 2018 Apr;25(2):149-162
pubmed: 29719431
CMAJ. 2000 Aug 8;163(3):283-4
pubmed: 10951725
Psychooncology. 2014 Mar;23(3):330-8
pubmed: 24123482
J Clin Oncol. 2006 Aug 1;24(22):3527-34
pubmed: 16822844
BMC Med Res Methodol. 2015 Aug 12;15:60
pubmed: 26264621
Epidemiol Rev. 2017 Jan 1;39(1):71-92
pubmed: 28453622
Expert Rev Pharmacoecon Outcomes Res. 2014 Apr;14(2):221-33
pubmed: 24625040
Med Care. 2007 Mar;45(3):259-63
pubmed: 17304084
Cancer. 2017 Apr 1;123(7):1249-1258
pubmed: 27893938
J Exerc Rehabil. 2015 Feb 28;11(1):20-9
pubmed: 25830140
Ann Behav Med. 2009 Feb;37(1):10-9
pubmed: 19255819
J Natl Cancer Inst. 2012 Jun 6;104(11):815-40
pubmed: 22570317
Qual Life Res. 1994 Feb;3(1):7-12
pubmed: 8142947
J Eval Clin Pract. 2017 Apr;23(2):377-381
pubmed: 27592691
J Geriatr Phys Ther. 2020 Jul/Sep;43(3):153-158
pubmed: 30807554
Curr Oncol. 2017 Oct;24(5):284-294
pubmed: 29089795
Clin J Oncol Nurs. 2015 Apr;19(2):213-7
pubmed: 25840387
Psychooncology. 2009 Apr;18(4):412-21
pubmed: 19241491
Percept Psychophys. 1983 Sep;34(3):280-8
pubmed: 6646971
J Phys Act Health. 2008 Sep;5(5):688-705
pubmed: 18820344
Head Neck. 2009 Aug;31(8):994-1005
pubmed: 19340875
N Am J Sports Phys Ther. 2010 Sep;5(3):98-110
pubmed: 21589666
BMC Med Res Methodol. 2016 May 04;16:49
pubmed: 27145829
Support Care Cancer. 2016 Nov;24(11):4597-606
pubmed: 27312845
Med J Aust. 2018 Aug 20;209(4):184-187
pubmed: 29719196
Appl Physiol Nutr Metab. 2011 Aug;36(4):503-14
pubmed: 21848444
J Clin Oncol. 1993 Mar;11(3):570-9
pubmed: 8445433
J Clin Oncol. 2007 Oct 1;25(28):4396-404
pubmed: 17785708
Prev Med Rep. 2017 Aug 15;8:72-78
pubmed: 28856084
J Cancer Surviv. 2010 Jun;4(2):87-100
pubmed: 20052559
Health Rep. 2011 Mar;22(1):7-14
pubmed: 21510585
Cancer. 2019 Oct 1;125(19):3437-3447
pubmed: 31206630
Health Qual Life Outcomes. 2007 Dec 21;5:70
pubmed: 18154669
Aging (Milano). 1998 Feb;10(1):26-31
pubmed: 9589748
Curr Oncol. 2009 Jan;16(1):55
pubmed: 19229371
J Cancer Surviv. 2014 Mar;8(1):143-9
pubmed: 24234894
J Hand Ther. 2000 Jan-Mar;13(1):46-51
pubmed: 10718222
Cancer Nurs. 2015 Nov-Dec;38(6):417-25
pubmed: 25539165
J Cancer Surviv. 2015 Sep;9(3):532-40
pubmed: 25666749
Med Oncol. 2011 Sep;28(3):753-65
pubmed: 20411366
Int J Sports Med. 1982 Aug;3(3):153-8
pubmed: 7129724
Pharmacoeconomics. 2007;25(5):365-84
pubmed: 17488136
Aust Occup Ther J. 2011 Apr;58(2):82-7
pubmed: 21418230
Curr Oncol. 2014 Oct;21(5):267-71
pubmed: 25302035

Auteurs

Margaret L McNeely (ML)

Physical Therapy, University of Alberta, Edmonton, Alberta, Canada mmcneely@ualberta.ca.
Rehabilitation Medicine, Cross Cancer Institute, Edmonton, Alberta, Canada.

Christopher Sellar (C)

Physical Therapy, University of Alberta, Edmonton, Alberta, Canada.

Tanya Williamson (T)

Kinesiology, University of Calgary, Calgary, Alberta, Canada.

Melissa Shea-Budgell (M)

Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.

Anil Abraham Joy (AA)

Division of Medical Oncology, Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.

Harold Y Lau (HY)

Oncology, University of Calgary, Calgary, Alberta, Canada.

Jacob C Easaw (JC)

Medical Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada.

Albert D Murtha (AD)

Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada.

Jeffrey Vallance (J)

Faculty of Health Disciplines, Athabasca University, Medicine Hat, Alberta, Canada.

Kerry Courneya (K)

Faculty of Kinesiology, Sport, and Recreation, University of Alberta, Edmonton, Alberta, Canada.

John R Mackey (JR)

Oncology, University of Alberta, Edmonton, Alberta, Canada.

Matthew Parliament (M)

Radiation Oncology, University of Alberta Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada.

Nicole Culos-Reed (N)

Kinesiology, University of Calgary, Calgary, Alberta, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH